132 related articles for article (PubMed ID: 35034110)
41. Perceptions of risk and therapy among patients with Barrett's esophagus: a patient survey study.
Stier MW; Lodhia N; Jacobs J; Nozicka D; Kavitt R; Siddiqui U; Waxman I; Konda VJ
Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036278
[TBL] [Abstract][Full Text] [Related]
42. Stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia: report on a Brussels' cohort.
Pouw RE; Peters FP; Sempoux C; Piessevaux H; Deprez PH
Endoscopy; 2008 Nov; 40(11):892-8. PubMed ID: 19009481
[TBL] [Abstract][Full Text] [Related]
43. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem.
Rusch VW; Levine DS; Haggitt R; Reid BJ
Cancer; 1994 Aug; 74(4):1225-9. PubMed ID: 8055442
[TBL] [Abstract][Full Text] [Related]
44. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia.
Falk GW; Rice TW; Goldblum JR; Richter JE
Gastrointest Endosc; 1999 Feb; 49(2):170-6. PubMed ID: 9925694
[TBL] [Abstract][Full Text] [Related]
45. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
46. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
[TBL] [Abstract][Full Text] [Related]
47. High definition versus standard definition white light endoscopy for detecting dysplasia in patients with Barrett's esophagus.
Sami SS; Subramanian V; Butt WM; Bejkar G; Coleman J; Mannath J; Ragunath K
Dis Esophagus; 2015; 28(8):742-9. PubMed ID: 25209721
[TBL] [Abstract][Full Text] [Related]
48. Rapid progression of Barrett's esophagus to metastatic esophageal carcinoma in a patient with chronic lymphocytic leukemia.
Hsu CW; Krevsky B; Sigman LM; Thomas RM
J Clin Gastroenterol; 1998 Oct; 27(3):261-4. PubMed ID: 9802460
[TBL] [Abstract][Full Text] [Related]
49. Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error.
Peters FP; Curvers WL; Rosmolen WD; de Vries CE; Ten Kate FJ; Krishnadath KK; Fockens P; Bergman JJ
Dis Esophagus; 2008; 21(6):475-9. PubMed ID: 18430186
[TBL] [Abstract][Full Text] [Related]
50. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
Cameron AJ; Carpenter HA
Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
[TBL] [Abstract][Full Text] [Related]
51. Endoscopic surveillance of Barrett's esophagus. Does it help?
Streitz JM; Andrews CW; Ellis FH
J Thorac Cardiovasc Surg; 1993 Mar; 105(3):383-7; discussion 387-8. PubMed ID: 8445916
[TBL] [Abstract][Full Text] [Related]
52. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus.
Geisinger KR; Teot LA; Richter JE
Cancer; 1992 Jan; 69(1):8-16. PubMed ID: 1727677
[TBL] [Abstract][Full Text] [Related]
53. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
54. Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus.
Chang LC; Oelschlager BK; Quiroga E; Parra JD; Mulligan M; Wood DE; Pellegrini CA
J Gastrointest Surg; 2006 Mar; 10(3):341-6. PubMed ID: 16504878
[TBL] [Abstract][Full Text] [Related]
55. Diagnosing dysplasia in Barrett's oesophagus still requires Seattle protocol biopsy in the era of modern video endoscopy: results from a tertiary centre Barrett's dysplasia database.
Nachiappan A; Ragunath K; Card T; Kaye P
Scand J Gastroenterol; 2020 Jan; 55(1):9-13. PubMed ID: 31880176
[No Abstract] [Full Text] [Related]
56. A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance.
Gudlaugsdottir S; van Blankenstein M; Dees J; Wilson JH
Eur J Gastroenterol Hepatol; 2001 Jun; 13(6):639-45. PubMed ID: 11434588
[TBL] [Abstract][Full Text] [Related]
57. Adenocarcinoma arising in Barrett's esophagus.
Ovaska J; Miettinen M; Kivilaakso E
Dig Dis Sci; 1989 Sep; 34(9):1336-9. PubMed ID: 2766899
[TBL] [Abstract][Full Text] [Related]
58. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort.
Reid BJ; Blount PL; Rubin CE; Levine DS; Haggitt RC; Rabinovitch PS
Gastroenterology; 1992 Apr; 102(4 Pt 1):1212-9. PubMed ID: 1551528
[TBL] [Abstract][Full Text] [Related]
59. Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett's esophagus.
Ishihara R; Goda K; Oyama T
J Gastroenterol; 2019 Jan; 54(1):1-9. PubMed ID: 29961130
[TBL] [Abstract][Full Text] [Related]
60. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
